Faron Pharmaceuticals Oy (LON:FARN) insider Frank Armstrong bought 1,250 shares of the firm’s stock in a transaction on Wednesday, October 11th. The shares were bought at an average cost of GBX 800 ($10.52) per share, for a total transaction of £10,000 ($13,147.52).

Shares of Faron Pharmaceuticals Oy (FARN) opened at 840.00 on Friday. The company’s market cap is GBX 229.24 million. Faron Pharmaceuticals Oy has a 52 week low of GBX 245.00 and a 52 week high of GBX 875.00. The company has a 50 day moving average of GBX 787.97 and a 200 day moving average of GBX 727.18.

COPYRIGHT VIOLATION WARNING: “Frank Armstrong Buys 1,250 Shares of Faron Pharmaceuticals Oy (FARN) Stock” was posted by American Banking News and is owned by of American Banking News. If you are reading this piece on another publication, it was copied illegally and republished in violation of United States and international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2017/10/13/frank-armstrong-buys-1250-shares-of-faron-pharmaceuticals-oy-farn-stock.html.

Separately, Panmure Gordon reissued a “buy” rating on shares of Faron Pharmaceuticals Oy in a research note on Monday, October 2nd.

Faron Pharmaceuticals Oy Company Profile

Receive News & Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related companies with MarketBeat.com's FREE daily email newsletter.